Satsuma Pharmaceuticals ROE Ratio 2011-2026 | STSA

Annual ROE Ratio Satsuma Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-149.61	-50.5	-66.12	-24.43	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-24.43	-149.61	-72.66

Quarterly ROE Ratio Satsuma Pharmaceuticals

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-94.16	-62.52	-74.04	-63.43	-50.15	-28.36	-45.7	-50.92	-57.32	-66.12	-58.14	-48.56	-38.35	-24.43	4.26	24.51	56.61	59.05	39.73	26.64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
59.05	-94.16	-27.57

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-36.22	$ 3.85	3.22 %	$ 9.26 B	Australia
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	39.76	$ 326.45	-2.08 %	$ 42.8 B	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Burford Capital Limited BUR	10.1	$ 4.71	-0.42 %	$ 766 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Cabaletta Bio CABA	-149.8	$ 3.49	2.65 %	$ 351 M	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	-45.18	$ 8.14	9.7 %	$ 80.5 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	103.22	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	12.44	$ 21.85	0.78 %	$ 1.02 B	USA
CymaBay Therapeutics CBAY	-36.05	-	-	$ 3.45 B	USA
BioNTech SE BNTX	1.11	$ 101.25	1.78 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	-175.75	$ 3.15	-0.63 %	$ 5.19 M	Israel
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	549.72	-	-5.16 %	$ 5.39 M	USA
Galectin Therapeutics GALT	24.11	$ 2.3	-10.16 %	$ 147 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	-16.39	$ 1.4	-10.0 %	$ 360 M	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	248.9	$ 4.22	-0.5 %	$ 451 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 23.98	-2.44 %	$ 3.05 B	USA
Grifols, S.A. GRFS	9.2	$ 8.58	-1.29 %	$ 6.83 B	Spain
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	45.18	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	-161.42	$ 1.53	2.35 %	$ 407 M	Britain
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	445.47	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-67.58	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	204.15	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	-49.08	$ 33.75	-0.35 %	$ 2.24 B	USA
bluebird bio BLUE	-108.93	-	-	$ 546 M	USA